Highlights
- Market Cap
- $8.32B
- Enterprise Value
- $9.13B
- EPS (TTM)
- $1.98
- PE Ratio
- 20.24
- PEG Ratio
- 0.16
- Total Revenue (TTM)
- $2.09B
- Gross Profit (TTM)
- $1.29B
- EBITDA (TTM)
- $717.27M
- Year Range
- $38.80 - $57.82
- Target Price
- $54.80
- ROA (TTM)
- 6.75%
- ROE (TTM)
- 11.25%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Qiagen N.V., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Qiagen N.V. (QGEN) has returned -11.11% so far this year and 0.08% over the past 12 months. Over the last ten years, QGEN has returned 5.75% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Qiagen N.V.
- 1D
- 1.83%
- 1M
- -19.60%
- YTD
- -11.11%
- 6M
- -10.54%
- 1Y
- 0.08%
- 3Y*
- -4.39%
- 5Y*
- -4.02%
- 10Y*
- 5.75%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jun 28, 1996, QGEN's average daily return is +0.07%, while the average monthly return is +1.49%. At this rate, your investment would double in approximately 3.9 years.
Historically, 51% of months were positive and 49% were negative. The best month was Feb 2000 with a return of +76.5%, while the worst month was Jul 2002 at -40.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.
On a daily basis, QGEN closed higher 50% of trading days. The best single day was Jan 10, 2000 with a return of +25.0%, while the worst single day was Jul 3, 2002 at -30.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 19.15% | -7.21% | -19.60% | -11.11% | |||||||||
| 2025 | 0.25% | -13.98% | 4.56% | 6.48% | 5.57% | 6.49% | 3.20% | -5.76% | -3.91% | 4.86% | 1.92% | -5.82% | 1.51% |
| 2024 | 0.44% | -1.99% | 0.47% | -1.54% | 2.20% | -5.02% | 8.27% | 2.74% | -0.31% | -7.61% | 3.16% | 2.53% | 2.44% |
| 2023 | -1.74% | -6.22% | -0.04% | -2.87% | 1.23% | -0.29% | 3.98% | -2.84% | -10.97% | -7.58% | 9.97% | 5.52% | -12.91% |
| 2022 | -10.96% | 0.40% | -1.39% | -7.41% | 1.28% | 2.72% | 5.17% | -8.48% | -9.13% | 5.52% | 13.73% | 0.67% | -10.27% |
| 2021 | 2.46% | -7.66% | -2.62% | -1.15% | 2.56% | -1.99% | 9.12% | 5.74% | -7.42% | 7.89% | -1.13% | 0.82% | 5.17% |
Benchmark Metrics
Qiagen N.V. has an annualized alpha of 11.49%, beta of 0.80, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since July 01, 1996.
- This stock captured 108.70% of S&P 500 Index gains but only 96.06% of its losses — a favorable profile for investors.
- R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 11.49%
- Beta
- 0.80
- R²
- 0.14
- Upside Capture
- 108.70%
- Downside Capture
- 96.06%
Return for Risk
Risk / Return Rank
QGEN ranks 38 for risk / return — below 38% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Qiagen N.V. (QGEN) and compare them to a chosen benchmark (S&P 500 Index).
| QGEN | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.00 | 0.90 | -0.89 |
Sortino ratioReturn per unit of downside risk | 0.25 | 1.39 | -1.13 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.21 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | 0.03 | 1.40 | -1.37 |
Martin ratioReturn relative to average drawdown | 0.08 | 6.61 | -6.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore QGEN risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Qiagen N.V. provided a 6.38% dividend yield over the last twelve months, with an annual payout of $2.55 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.55 | $0.26 | $1.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.13 |
Dividend yield | 6.38% | 0.56% | 2.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.36% |
Monthly Dividends
The table displays the monthly dividend distributions for Qiagen N.V.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $2.29 | $0.00 | $0.00 | $2.29 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 |
| 2024 | $1.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.39 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Qiagen N.V. has a dividend yield of 6.38%, which means its dividend payment is significantly above the market average.
Payout Ratio
Qiagen N.V. has a payout ratio of 12.77%, which is below the market average. This means Qiagen N.V. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Qiagen N.V.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Qiagen N.V. was 92.14%, occurring on Oct 2, 2002. The portfolio has not yet recovered.
The current Qiagen N.V. drawdown is 29.97%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.14% | Jul 18, 2000 | 554 | Oct 2, 2002 | — | — | — |
| -47.3% | Mar 13, 2000 | 17 | Apr 4, 2000 | 71 | Jul 17, 2000 | 88 |
| -36.92% | Mar 23, 1998 | 141 | Oct 9, 1998 | 82 | Feb 8, 1999 | 223 |
| -35.17% | Jul 15, 1997 | 74 | Oct 27, 1997 | 94 | Mar 13, 1998 | 168 |
| -24.42% | Oct 14, 1996 | 16 | Nov 4, 1996 | 84 | Mar 6, 1997 | 100 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Qiagen N.V. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Qiagen N.V. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for QGEN, comparing it with other companies in the Diagnostics & Research industry. Currently, QGEN has a P/E ratio of 20.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for QGEN compared to other companies in the Diagnostics & Research industry. QGEN currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for QGEN relative to other companies in the Diagnostics & Research industry. Currently, QGEN has a P/S ratio of 4.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for QGEN in comparison with other companies in the Diagnostics & Research industry. Currently, QGEN has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |